advertisement
11.3.3 Apraclonidine, brimonidine (6)
Showing records 1 to 6
Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine
Search within classification 11.3.3 Apraclonidine, brimonidine14266 Is brimonidine ophthalmic a safe therapy for infants?
Daubert GP
Journal of Clinical Pharmacy and Therapeutics 2006; 31: 289-292
13978 Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: A 12-month randomized trial
Sherwood MB; Craven ER; Chou C; Dubiner HB; Batoosingh AL; Schiffman RM; Whitcup SM
Archives of Ophthalmology 2006; 124: 1230-1238
14270 Comparative analysis of the effects of brimonidine and dorzolamide on ocular blood flow velocity in patients with newly diagnosed primary open-angle glaucoma
Simsek T; Yanik B; Conkbayir I; Zilelioglu O
Journal of Ocular Pharmacology and Therapeutics 2006; 22: 79-85
14103 The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1
Whitson JT; Ochsner KI; Moster MR; Sullivan EK; Andrew RM; Silver LH; Wells DT; James JE; Bosworth CF; Dickerson JE
Ophthalmology 2006; 113: 1333-1339
14222 A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clinical Therapeutics 2006; 28: 552-559
14068 Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium: YAG laser posterior capsulotomy
Unal M; Yucel I; Akar Y
Journal of Cataract and Refractive Surgery 2006; 32: 1499-1502
